Delivery Order SPE2DB20D7059-SPE2DB25FQMF1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,656.65 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-competitive, non-set-aside award. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in HIV...
- The Defense Logistics Agency awarded a delivery order valued at $8,351.68 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed price delivery order, with a completion date of July 30, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,020.92 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, executed on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $19,989.93 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-unit packages). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 31, 2025, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a $34,787.81 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 25, 2025. The contract is performed from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) valued at $141,757, with a firm fixed price structure and no set-aside designation. The award was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under a larger contracting vehicle supporting the...
- The Defense Logistics Agency awarded a delivery order valued at $78,728.98 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets (30-count units). This competitively awarded, firm fixed-price contract was executed on July 30, 2025, with an ultimate completion date of July 31, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a $4,118.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. The delivery was completed by July 23, 2025, and performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This was a competitively awarded contract with no set-aside designation, reflecting the agency's standard procurement practices for pharmaceutical supplies...
- This delivery order, valued at $14,766.28 with an ultimate completion date of August 4, 2025, represents a Firm Fixed Price award to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. The contract was awarded without a set-aside designation on August 1, 2025, by the Defense Logistics Agency (DLA), the Department of Defense's logistics and supply distribution arm. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $29,406.51 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price, competitively awarded contract has an ultimate completion date of July 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting the critical pharmaceutical supply...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQMF1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,948.35 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by July 29, 2025, and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an FDA-approved antiretroviral medication used in the treatment of HIV, reflecting the Defense Logistics Agency's role in ensuring pharmaceutical availability for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen maintains a comprehensive portfolio of federal contracts supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The company's status as a prime vendor under this significant IDC demonstrates its capability to meet federal medical procurement requirements through open competition and positions it as a critical partner in the Defense Health Agency's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 7/28/25 |